nephrotoxicity
Originally slated to be released this summer, the guidance will detail the formal steps involved in qualifying biomarkers for FDA approval.
An FDA official said that the agency has formalized the "progressive" biomarker qualification process described in the paper and will be releasing a draft guidance detailing the formal steps of the process this July.